nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP2D6—Lomustine—brain cancer	0.114	0.191	CbGbCtD
Clonidine—CYP1A2—Carmustine—brain cancer	0.113	0.189	CbGbCtD
Clonidine—CYP2D6—Hydroxyurea—brain cancer	0.0867	0.145	CbGbCtD
Clonidine—CYP3A4—Temozolomide—brain cancer	0.0856	0.143	CbGbCtD
Clonidine—CYP3A4—Lomustine—brain cancer	0.0728	0.122	CbGbCtD
Clonidine—CYP3A5—Etoposide—brain cancer	0.0451	0.0754	CbGbCtD
Clonidine—CYP1A2—Etoposide—brain cancer	0.0336	0.0561	CbGbCtD
Clonidine—ABCB1—Etoposide—brain cancer	0.0293	0.049	CbGbCtD
Clonidine—CYP3A4—Etoposide—brain cancer	0.0176	0.0294	CbGbCtD
Clonidine—NISCH—Podofilox—Etoposide—brain cancer	0.00692	1	CbGdCrCtD
Clonidine—SLC22A1—ganglion—brain cancer	0.0033	0.0439	CbGeAlD
Clonidine—SLC6A2—ganglion—brain cancer	0.0027	0.0359	CbGeAlD
Clonidine—NISCH—telencephalon—brain cancer	0.00202	0.0269	CbGeAlD
Clonidine—ADRA1A—hindbrain—brain cancer	0.0019	0.0253	CbGeAlD
Clonidine—ADRA1D—telencephalon—brain cancer	0.00169	0.0224	CbGeAlD
Clonidine—NISCH—pituitary gland—brain cancer	0.00165	0.0219	CbGeAlD
Clonidine—NISCH—medulla oblongata—brain cancer	0.00159	0.0211	CbGeAlD
Clonidine—NISCH—midbrain—brain cancer	0.00145	0.0193	CbGeAlD
Clonidine—NISCH—spinal cord—brain cancer	0.00142	0.0188	CbGeAlD
Clonidine—Thrombocytopenia—Lomustine—brain cancer	0.00137	0.00557	CcSEcCtD
Clonidine—Pain—Carboplatin—brain cancer	0.00136	0.00556	CcSEcCtD
Clonidine—Sweating—Procarbazine—brain cancer	0.00133	0.00543	CcSEcCtD
Clonidine—Anorexia—Lomustine—brain cancer	0.00133	0.00542	CcSEcCtD
Clonidine—Epistaxis—Procarbazine—brain cancer	0.00131	0.00534	CcSEcCtD
Clonidine—Ear pain—Temozolomide—brain cancer	0.00128	0.0052	CcSEcCtD
Clonidine—SLC22A1—telencephalon—brain cancer	0.00127	0.0169	CbGeAlD
Clonidine—Body temperature increased—Carboplatin—brain cancer	0.00126	0.00514	CcSEcCtD
Clonidine—Breast disorder—Hydroxyurea—brain cancer	0.00126	0.00514	CcSEcCtD
Clonidine—Hallucination—Procarbazine—brain cancer	0.00124	0.00506	CcSEcCtD
Clonidine—Decreased appetite—Lomustine—brain cancer	0.00121	0.00494	CcSEcCtD
Clonidine—Nasal congestion—Temozolomide—brain cancer	0.0012	0.00487	CcSEcCtD
Clonidine—SLC6A2—brainstem—brain cancer	0.00117	0.0156	CbGeAlD
Clonidine—Thirst—Temozolomide—brain cancer	0.00115	0.00467	CcSEcCtD
Clonidine—Dysuria—Hydroxyurea—brain cancer	0.00113	0.00459	CcSEcCtD
Clonidine—NISCH—cerebellum—brain cancer	0.00112	0.0149	CbGeAlD
Clonidine—CYP2D6—hindbrain—brain cancer	0.00112	0.0149	CbGeAlD
Clonidine—Arrhythmia—Procarbazine—brain cancer	0.00111	0.00454	CcSEcCtD
Clonidine—Body temperature increased—Lomustine—brain cancer	0.0011	0.00449	CcSEcCtD
Clonidine—Alopecia—Procarbazine—brain cancer	0.0011	0.00449	CcSEcCtD
Clonidine—Weight increased—Hydroxyurea—brain cancer	0.0011	0.00447	CcSEcCtD
Clonidine—Rash maculo-papular—Etoposide—brain cancer	0.00109	0.00445	CcSEcCtD
Clonidine—ADRA1A—brainstem—brain cancer	0.00109	0.0145	CbGeAlD
Clonidine—SLC22A4—pituitary gland—brain cancer	0.00109	0.0145	CbGeAlD
Clonidine—Drowsiness—Hydroxyurea—brain cancer	0.00107	0.00438	CcSEcCtD
Clonidine—ADRA1B—head—brain cancer	0.00107	0.0143	CbGeAlD
Clonidine—Tension—Procarbazine—brain cancer	0.00107	0.00434	CcSEcCtD
Clonidine—ADRA1D—endocrine gland—brain cancer	0.00106	0.0141	CbGeAlD
Clonidine—Nervousness—Procarbazine—brain cancer	0.00105	0.0043	CcSEcCtD
Clonidine—ADRA1D—head—brain cancer	0.00105	0.014	CbGeAlD
Clonidine—SLC6A2—telencephalon—brain cancer	0.00104	0.0139	CbGeAlD
Clonidine—Liver function test abnormal—Carmustine—brain cancer	0.00104	0.00424	CcSEcCtD
Clonidine—Tremor—Procarbazine—brain cancer	0.00102	0.00414	CcSEcCtD
Clonidine—SLC22A3—gonad—brain cancer	0.00102	0.0135	CbGeAlD
Clonidine—Breast disorder—Temozolomide—brain cancer	0.000985	0.00401	CcSEcCtD
Clonidine—ADRA1B—central nervous system—brain cancer	0.00098	0.013	CbGeAlD
Clonidine—Syncope—Procarbazine—brain cancer	0.000973	0.00397	CcSEcCtD
Clonidine—ADRA1A—telencephalon—brain cancer	0.000969	0.0129	CbGeAlD
Clonidine—Cardiac failure congestive—Etoposide—brain cancer	0.000962	0.00392	CcSEcCtD
Clonidine—Hallucination—Hydroxyurea—brain cancer	0.00096	0.00391	CcSEcCtD
Clonidine—ADRA1D—central nervous system—brain cancer	0.000959	0.0127	CbGeAlD
Clonidine—Loss of consciousness—Procarbazine—brain cancer	0.000954	0.00389	CcSEcCtD
Clonidine—Cough—Procarbazine—brain cancer	0.000947	0.00386	CcSEcCtD
Clonidine—SLC22A4—spinal cord—brain cancer	0.000936	0.0125	CbGeAlD
Clonidine—Arthralgia—Procarbazine—brain cancer	0.000924	0.00377	CcSEcCtD
Clonidine—ADRA2C—telencephalon—brain cancer	0.000923	0.0123	CbGeAlD
Clonidine—Anxiety—Procarbazine—brain cancer	0.000921	0.00375	CcSEcCtD
Clonidine—NISCH—brain—brain cancer	0.000912	0.0121	CbGeAlD
Clonidine—Dry mouth—Procarbazine—brain cancer	0.000904	0.00368	CcSEcCtD
Clonidine—Confusional state—Procarbazine—brain cancer	0.000893	0.00364	CcSEcCtD
Clonidine—Vomiting—Lomustine—brain cancer	0.000887	0.00362	CcSEcCtD
Clonidine—Oedema—Procarbazine—brain cancer	0.000886	0.00361	CcSEcCtD
Clonidine—Dysuria—Temozolomide—brain cancer	0.000881	0.00359	CcSEcCtD
Clonidine—Infection—Procarbazine—brain cancer	0.00088	0.00359	CcSEcCtD
Clonidine—Angiopathy—Hydroxyurea—brain cancer	0.000876	0.00357	CcSEcCtD
Clonidine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000875	0.00357	CcSEcCtD
Clonidine—Shock—Procarbazine—brain cancer	0.000872	0.00355	CcSEcCtD
Clonidine—Pollakiuria—Temozolomide—brain cancer	0.00087	0.00355	CcSEcCtD
Clonidine—SLC6A2—gonad—brain cancer	0.00087	0.0116	CbGeAlD
Clonidine—Erectile dysfunction—Temozolomide—brain cancer	0.000867	0.00353	CcSEcCtD
Clonidine—Thrombocytopenia—Procarbazine—brain cancer	0.000867	0.00353	CcSEcCtD
Clonidine—Depression—Carmustine—brain cancer	0.000866	0.00353	CcSEcCtD
Clonidine—Tachycardia—Procarbazine—brain cancer	0.000865	0.00352	CcSEcCtD
Clonidine—Weight increased—Temozolomide—brain cancer	0.000857	0.00349	CcSEcCtD
Clonidine—Hyperhidrosis—Procarbazine—brain cancer	0.000856	0.00349	CcSEcCtD
Clonidine—Alopecia—Hydroxyurea—brain cancer	0.000853	0.00347	CcSEcCtD
Clonidine—ABCB1—blood vessel—brain cancer	0.000846	0.0113	CbGeAlD
Clonidine—Urinary tract infection—Carmustine—brain cancer	0.000845	0.00344	CcSEcCtD
Clonidine—Anorexia—Procarbazine—brain cancer	0.000844	0.00344	CcSEcCtD
Clonidine—Erythema—Hydroxyurea—brain cancer	0.00084	0.00342	CcSEcCtD
Clonidine—Depression—Temozolomide—brain cancer	0.000837	0.00341	CcSEcCtD
Clonidine—Nausea—Lomustine—brain cancer	0.000829	0.00338	CcSEcCtD
Clonidine—Hypotension—Procarbazine—brain cancer	0.000828	0.00337	CcSEcCtD
Clonidine—SLC6A2—medulla oblongata—brain cancer	0.000819	0.0109	CbGeAlD
Clonidine—Urinary tract infection—Temozolomide—brain cancer	0.000816	0.00333	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000807	0.00329	CcSEcCtD
Clonidine—SLC22A1—endocrine gland—brain cancer	0.000803	0.0107	CbGeAlD
Clonidine—Insomnia—Procarbazine—brain cancer	0.000801	0.00327	CcSEcCtD
Clonidine—Paraesthesia—Procarbazine—brain cancer	0.000795	0.00324	CcSEcCtD
Clonidine—SLC22A1—head—brain cancer	0.000792	0.0105	CbGeAlD
Clonidine—Somnolence—Procarbazine—brain cancer	0.000788	0.00321	CcSEcCtD
Clonidine—Cramp muscle—Etoposide—brain cancer	0.000785	0.0032	CcSEcCtD
Clonidine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000779	0.00318	CcSEcCtD
Clonidine—ADRA1B—brain—brain cancer	0.000778	0.0103	CbGeAlD
Clonidine—Hallucination—Carmustine—brain cancer	0.000776	0.00316	CcSEcCtD
Clonidine—Hypoaesthesia—Carmustine—brain cancer	0.000776	0.00316	CcSEcCtD
Clonidine—Decreased appetite—Procarbazine—brain cancer	0.00077	0.00314	CcSEcCtD
Clonidine—SLC22A3—endocrine gland—brain cancer	0.000767	0.0102	CbGeAlD
Clonidine—Fatigue—Procarbazine—brain cancer	0.000764	0.00311	CcSEcCtD
Clonidine—ADRA1D—brain—brain cancer	0.000761	0.0101	CbGeAlD
Clonidine—Malaise—Hydroxyurea—brain cancer	0.000758	0.00309	CcSEcCtD
Clonidine—Pain—Procarbazine—brain cancer	0.000758	0.00309	CcSEcCtD
Clonidine—Constipation—Procarbazine—brain cancer	0.000758	0.00309	CcSEcCtD
Clonidine—SLC22A3—head—brain cancer	0.000757	0.0101	CbGeAlD
Clonidine—Hepatitis—Temozolomide—brain cancer	0.000754	0.00307	CcSEcCtD
Clonidine—ADRA2C—pituitary gland—brain cancer	0.000752	0.01	CbGeAlD
Clonidine—Hypoaesthesia—Temozolomide—brain cancer	0.00075	0.00306	CcSEcCtD
Clonidine—Hallucination—Temozolomide—brain cancer	0.00075	0.00306	CcSEcCtD
Clonidine—SLC22A4—cerebellum—brain cancer	0.000742	0.00987	CbGeAlD
Clonidine—ADRA2A—telencephalon—brain cancer	0.000737	0.0098	CbGeAlD
Clonidine—Feeling abnormal—Procarbazine—brain cancer	0.00073	0.00297	CcSEcCtD
Clonidine—Eye disorder—Carmustine—brain cancer	0.000729	0.00297	CcSEcCtD
Clonidine—ADRA2C—medulla oblongata—brain cancer	0.000725	0.00965	CbGeAlD
Clonidine—Gastrointestinal pain—Procarbazine—brain cancer	0.000724	0.00295	CcSEcCtD
Clonidine—SLC22A1—central nervous system—brain cancer	0.000723	0.00962	CbGeAlD
Clonidine—SLC22A5—pituitary gland—brain cancer	0.00072	0.00957	CbGeAlD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00071	0.00289	CcSEcCtD
Clonidine—Discomfort—Hydroxyurea—brain cancer	0.000707	0.00288	CcSEcCtD
Clonidine—Eye disorder—Temozolomide—brain cancer	0.000705	0.00287	CcSEcCtD
Clonidine—Urticaria—Procarbazine—brain cancer	0.000704	0.00287	CcSEcCtD
Clonidine—Tinnitus—Temozolomide—brain cancer	0.000703	0.00286	CcSEcCtD
Clonidine—Abdominal pain—Procarbazine—brain cancer	0.0007	0.00285	CcSEcCtD
Clonidine—Body temperature increased—Procarbazine—brain cancer	0.0007	0.00285	CcSEcCtD
Clonidine—Cardiac disorder—Temozolomide—brain cancer	0.0007	0.00285	CcSEcCtD
Clonidine—Arrhythmia—Carmustine—brain cancer	0.000697	0.00284	CcSEcCtD
Clonidine—SLC22A5—medulla oblongata—brain cancer	0.000695	0.00924	CbGeAlD
Clonidine—SLC22A3—central nervous system—brain cancer	0.000691	0.00919	CbGeAlD
Clonidine—Alopecia—Carmustine—brain cancer	0.000689	0.00281	CcSEcCtD
Clonidine—Oedema—Hydroxyurea—brain cancer	0.000686	0.00279	CcSEcCtD
Clonidine—Angiopathy—Temozolomide—brain cancer	0.000684	0.00279	CcSEcCtD
Clonidine—Mental disorder—Carmustine—brain cancer	0.000683	0.00279	CcSEcCtD
Clonidine—Infection—Hydroxyurea—brain cancer	0.000681	0.00278	CcSEcCtD
Clonidine—Mediastinal disorder—Temozolomide—brain cancer	0.000679	0.00277	CcSEcCtD
Clonidine—Erythema—Carmustine—brain cancer	0.000679	0.00277	CcSEcCtD
Clonidine—Nervous system disorder—Hydroxyurea—brain cancer	0.000672	0.00274	CcSEcCtD
Clonidine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000671	0.00274	CcSEcCtD
Clonidine—Alopecia—Temozolomide—brain cancer	0.000666	0.00271	CcSEcCtD
Clonidine—Skin disorder—Hydroxyurea—brain cancer	0.000666	0.00271	CcSEcCtD
Clonidine—ADRA2C—midbrain—brain cancer	0.000663	0.00882	CbGeAlD
Clonidine—Mental disorder—Temozolomide—brain cancer	0.00066	0.00269	CcSEcCtD
Clonidine—SLC6A2—endocrine gland—brain cancer	0.000657	0.00874	CbGeAlD
Clonidine—Erythema—Temozolomide—brain cancer	0.000656	0.00267	CcSEcCtD
Clonidine—Anorexia—Hydroxyurea—brain cancer	0.000654	0.00266	CcSEcCtD
Clonidine—Hypersensitivity—Procarbazine—brain cancer	0.000653	0.00266	CcSEcCtD
Clonidine—SLC6A2—head—brain cancer	0.000649	0.00863	CbGeAlD
Clonidine—ADRA2C—spinal cord—brain cancer	0.000647	0.0086	CbGeAlD
Clonidine—CYP2D6—brainstem—brain cancer	0.000643	0.00855	CbGeAlD
Clonidine—Vision blurred—Carmustine—brain cancer	0.00064	0.00261	CcSEcCtD
Clonidine—Diclofenac—CYP2C9—brain cancer	0.000637	1	CrCbGaD
Clonidine—Tremor—Carmustine—brain cancer	0.000636	0.00259	CcSEcCtD
Clonidine—Asthenia—Procarbazine—brain cancer	0.000636	0.00259	CcSEcCtD
Clonidine—SLC22A5—midbrain—brain cancer	0.000635	0.00844	CbGeAlD
Clonidine—Pruritus—Procarbazine—brain cancer	0.000627	0.00255	CcSEcCtD
Clonidine—Agitation—Carmustine—brain cancer	0.000624	0.00254	CcSEcCtD
Clonidine—SLC22A5—spinal cord—brain cancer	0.00062	0.00824	CbGeAlD
Clonidine—Vision blurred—Temozolomide—brain cancer	0.000618	0.00252	CcSEcCtD
Clonidine—ADRA2A—gonad—brain cancer	0.000615	0.00818	CbGeAlD
Clonidine—Tremor—Temozolomide—brain cancer	0.000615	0.00251	CcSEcCtD
Clonidine—Dyspnoea—Hydroxyurea—brain cancer	0.000611	0.00249	CcSEcCtD
Clonidine—ADRA1A—endocrine gland—brain cancer	0.000611	0.00813	CbGeAlD
Clonidine—Somnolence—Hydroxyurea—brain cancer	0.000609	0.00248	CcSEcCtD
Clonidine—Ill-defined disorder—Temozolomide—brain cancer	0.000609	0.00248	CcSEcCtD
Clonidine—Diarrhoea—Procarbazine—brain cancer	0.000606	0.00247	CcSEcCtD
Clonidine—ADRA1A—head—brain cancer	0.000603	0.00802	CbGeAlD
Clonidine—Agitation—Temozolomide—brain cancer	0.000603	0.00246	CcSEcCtD
Clonidine—SLC22A4—brain—brain cancer	0.000603	0.00802	CbGeAlD
Clonidine—Hypoaesthesia—Etoposide—brain cancer	0.0006	0.00245	CcSEcCtD
Clonidine—ADRA2A—pituitary gland—brain cancer	0.0006	0.00798	CbGeAlD
Clonidine—Angioedema—Temozolomide—brain cancer	0.0006	0.00244	CcSEcCtD
Clonidine—Decreased appetite—Hydroxyurea—brain cancer	0.000596	0.00243	CcSEcCtD
Clonidine—SLC6A2—central nervous system—brain cancer	0.000592	0.00788	CbGeAlD
Clonidine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000592	0.00241	CcSEcCtD
Clonidine—Malaise—Temozolomide—brain cancer	0.000592	0.00241	CcSEcCtD
Clonidine—Fatigue—Hydroxyurea—brain cancer	0.000591	0.00241	CcSEcCtD
Clonidine—Pain—Hydroxyurea—brain cancer	0.000586	0.00239	CcSEcCtD
Clonidine—Constipation—Hydroxyurea—brain cancer	0.000586	0.00239	CcSEcCtD
Clonidine—Dizziness—Procarbazine—brain cancer	0.000586	0.00239	CcSEcCtD
Clonidine—Palpitations—Temozolomide—brain cancer	0.00058	0.00236	CcSEcCtD
Clonidine—ADRA2A—medulla oblongata—brain cancer	0.000579	0.0077	CbGeAlD
Clonidine—Chest pain—Carmustine—brain cancer	0.000578	0.00236	CcSEcCtD
Clonidine—Anxiety—Carmustine—brain cancer	0.000576	0.00235	CcSEcCtD
Clonidine—ADRA2C—head—brain cancer	0.000575	0.00764	CbGeAlD
Clonidine—SLC22A1—brain—brain cancer	0.000574	0.00764	CbGeAlD
Clonidine—Cough—Temozolomide—brain cancer	0.000573	0.00233	CcSEcCtD
Clonidine—CYP2D6—telencephalon—brain cancer	0.000571	0.00759	CbGeAlD
Clonidine—Feeling abnormal—Hydroxyurea—brain cancer	0.000565	0.0023	CcSEcCtD
Clonidine—Eye disorder—Etoposide—brain cancer	0.000564	0.0023	CcSEcCtD
Clonidine—Vomiting—Procarbazine—brain cancer	0.000563	0.0023	CcSEcCtD
Clonidine—Cardiac disorder—Etoposide—brain cancer	0.00056	0.00228	CcSEcCtD
Clonidine—Confusional state—Carmustine—brain cancer	0.000559	0.00228	CcSEcCtD
Clonidine—Arthralgia—Temozolomide—brain cancer	0.000559	0.00228	CcSEcCtD
Clonidine—Rash—Procarbazine—brain cancer	0.000559	0.00228	CcSEcCtD
Clonidine—Dermatitis—Procarbazine—brain cancer	0.000558	0.00227	CcSEcCtD
Clonidine—Anxiety—Temozolomide—brain cancer	0.000557	0.00227	CcSEcCtD
Clonidine—Headache—Procarbazine—brain cancer	0.000555	0.00226	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000555	0.00226	CcSEcCtD
Clonidine—Oedema—Carmustine—brain cancer	0.000554	0.00226	CcSEcCtD
Clonidine—Discomfort—Temozolomide—brain cancer	0.000552	0.00225	CcSEcCtD
Clonidine—ADRA1A—central nervous system—brain cancer	0.000551	0.00732	CbGeAlD
Clonidine—Infection—Carmustine—brain cancer	0.000551	0.00224	CcSEcCtD
Clonidine—SLC22A3—brain—brain cancer	0.000549	0.0073	CbGeAlD
Clonidine—Angiopathy—Etoposide—brain cancer	0.000547	0.00223	CcSEcCtD
Clonidine—Dry mouth—Temozolomide—brain cancer	0.000546	0.00223	CcSEcCtD
Clonidine—Mediastinal disorder—Etoposide—brain cancer	0.000544	0.00222	CcSEcCtD
Clonidine—Thrombocytopenia—Carmustine—brain cancer	0.000543	0.00221	CcSEcCtD
Clonidine—Body temperature increased—Hydroxyurea—brain cancer	0.000542	0.00221	CcSEcCtD
Clonidine—Tachycardia—Carmustine—brain cancer	0.000541	0.0022	CcSEcCtD
Clonidine—Confusional state—Temozolomide—brain cancer	0.00054	0.0022	CcSEcCtD
Clonidine—ADRA1A—cerebellum—brain cancer	0.000538	0.00716	CbGeAlD
Clonidine—Oedema—Temozolomide—brain cancer	0.000536	0.00218	CcSEcCtD
Clonidine—Alopecia—Etoposide—brain cancer	0.000533	0.00217	CcSEcCtD
Clonidine—Infection—Temozolomide—brain cancer	0.000532	0.00217	CcSEcCtD
Clonidine—ADRA2A—midbrain—brain cancer	0.000529	0.00703	CbGeAlD
Clonidine—Anorexia—Carmustine—brain cancer	0.000528	0.00215	CcSEcCtD
Clonidine—Nausea—Procarbazine—brain cancer	0.000526	0.00214	CcSEcCtD
Clonidine—Nervous system disorder—Temozolomide—brain cancer	0.000525	0.00214	CcSEcCtD
Clonidine—ADRA2C—central nervous system—brain cancer	0.000525	0.00698	CbGeAlD
Clonidine—Thrombocytopenia—Temozolomide—brain cancer	0.000524	0.00214	CcSEcCtD
Clonidine—Skin disorder—Temozolomide—brain cancer	0.00052	0.00212	CcSEcCtD
Clonidine—Hypotension—Carmustine—brain cancer	0.000518	0.00211	CcSEcCtD
Clonidine—Hyperhidrosis—Temozolomide—brain cancer	0.000518	0.00211	CcSEcCtD
Clonidine—ADRA2A—spinal cord—brain cancer	0.000516	0.00686	CbGeAlD
Clonidine—ADRA2C—cerebellum—brain cancer	0.000513	0.00682	CbGeAlD
Clonidine—Anorexia—Temozolomide—brain cancer	0.000511	0.00208	CcSEcCtD
Clonidine—CYP1A2—endocrine gland—brain cancer	0.000505	0.00672	CbGeAlD
Clonidine—Hypersensitivity—Hydroxyurea—brain cancer	0.000505	0.00206	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000505	0.00206	CcSEcCtD
Clonidine—Muscle spasms—Etoposide—brain cancer	0.000505	0.00206	CcSEcCtD
Clonidine—Insomnia—Carmustine—brain cancer	0.000501	0.00204	CcSEcCtD
Clonidine—CYP1A1—endocrine gland—brain cancer	0.000498	0.00663	CbGeAlD
Clonidine—Paraesthesia—Carmustine—brain cancer	0.000498	0.00203	CcSEcCtD
Clonidine—Dyspnoea—Carmustine—brain cancer	0.000494	0.00201	CcSEcCtD
Clonidine—Somnolence—Carmustine—brain cancer	0.000493	0.00201	CcSEcCtD
Clonidine—CYP1A1—head—brain cancer	0.000492	0.00654	CbGeAlD
Clonidine—Asthenia—Hydroxyurea—brain cancer	0.000492	0.002	CcSEcCtD
Clonidine—SLC22A5—cerebellum—brain cancer	0.000491	0.00653	CbGeAlD
Clonidine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000488	0.00199	CcSEcCtD
Clonidine—CYP3A5—endocrine gland—brain cancer	0.000487	0.00648	CbGeAlD
Clonidine—Ill-defined disorder—Etoposide—brain cancer	0.000487	0.00199	CcSEcCtD
Clonidine—Insomnia—Temozolomide—brain cancer	0.000484	0.00197	CcSEcCtD
Clonidine—Decreased appetite—Carmustine—brain cancer	0.000482	0.00196	CcSEcCtD
Clonidine—Paraesthesia—Temozolomide—brain cancer	0.000481	0.00196	CcSEcCtD
Clonidine—Gastrointestinal disorder—Carmustine—brain cancer	0.000478	0.00195	CcSEcCtD
Clonidine—Dyspnoea—Temozolomide—brain cancer	0.000477	0.00195	CcSEcCtD
Clonidine—Somnolence—Temozolomide—brain cancer	0.000476	0.00194	CcSEcCtD
Clonidine—Constipation—Carmustine—brain cancer	0.000474	0.00193	CcSEcCtD
Clonidine—Pain—Carmustine—brain cancer	0.000474	0.00193	CcSEcCtD
Clonidine—Malaise—Etoposide—brain cancer	0.000474	0.00193	CcSEcCtD
Clonidine—SLC6A2—brain—brain cancer	0.00047	0.00625	CbGeAlD
Clonidine—Diarrhoea—Hydroxyurea—brain cancer	0.000469	0.00191	CcSEcCtD
Clonidine—Decreased appetite—Temozolomide—brain cancer	0.000466	0.0019	CcSEcCtD
Clonidine—ADRA2A—endocrine gland—brain cancer	0.000465	0.00618	CbGeAlD
Clonidine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000462	0.00188	CcSEcCtD
Clonidine—Fatigue—Temozolomide—brain cancer	0.000462	0.00188	CcSEcCtD
Clonidine—Loss of consciousness—Etoposide—brain cancer	0.000462	0.00188	CcSEcCtD
Clonidine—ADRA2A—head—brain cancer	0.000459	0.0061	CbGeAlD
Clonidine—Cough—Etoposide—brain cancer	0.000458	0.00187	CcSEcCtD
Clonidine—Pain—Temozolomide—brain cancer	0.000458	0.00187	CcSEcCtD
Clonidine—Constipation—Temozolomide—brain cancer	0.000458	0.00187	CcSEcCtD
Clonidine—Feeling abnormal—Carmustine—brain cancer	0.000457	0.00186	CcSEcCtD
Clonidine—Dizziness—Hydroxyurea—brain cancer	0.000453	0.00185	CcSEcCtD
Clonidine—Gastrointestinal pain—Carmustine—brain cancer	0.000453	0.00185	CcSEcCtD
Clonidine—CYP1A1—central nervous system—brain cancer	0.000449	0.00597	CbGeAlD
Clonidine—Chest pain—Etoposide—brain cancer	0.000447	0.00182	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000444	0.00181	CcSEcCtD
Clonidine—Discomfort—Etoposide—brain cancer	0.000442	0.0018	CcSEcCtD
Clonidine—Feeling abnormal—Temozolomide—brain cancer	0.000441	0.0018	CcSEcCtD
Clonidine—Body temperature increased—Carmustine—brain cancer	0.000438	0.00179	CcSEcCtD
Clonidine—Abdominal pain—Carmustine—brain cancer	0.000438	0.00179	CcSEcCtD
Clonidine—Gastrointestinal pain—Temozolomide—brain cancer	0.000438	0.00178	CcSEcCtD
Clonidine—ADRA1A—brain—brain cancer	0.000437	0.00581	CbGeAlD
Clonidine—Vomiting—Hydroxyurea—brain cancer	0.000436	0.00178	CcSEcCtD
Clonidine—Rash—Hydroxyurea—brain cancer	0.000432	0.00176	CcSEcCtD
Clonidine—Confusional state—Etoposide—brain cancer	0.000432	0.00176	CcSEcCtD
Clonidine—Dermatitis—Hydroxyurea—brain cancer	0.000432	0.00176	CcSEcCtD
Clonidine—Headache—Hydroxyurea—brain cancer	0.000429	0.00175	CcSEcCtD
Clonidine—Infection—Etoposide—brain cancer	0.000426	0.00174	CcSEcCtD
Clonidine—Urticaria—Temozolomide—brain cancer	0.000425	0.00173	CcSEcCtD
Clonidine—Body temperature increased—Temozolomide—brain cancer	0.000423	0.00173	CcSEcCtD
Clonidine—Abdominal pain—Temozolomide—brain cancer	0.000423	0.00173	CcSEcCtD
Clonidine—Thrombocytopenia—Etoposide—brain cancer	0.00042	0.00171	CcSEcCtD
Clonidine—ADRA2A—central nervous system—brain cancer	0.000419	0.00557	CbGeAlD
Clonidine—Tachycardia—Etoposide—brain cancer	0.000418	0.0017	CcSEcCtD
Clonidine—ADRA2C—brain—brain cancer	0.000417	0.00554	CbGeAlD
Clonidine—Skin disorder—Etoposide—brain cancer	0.000416	0.0017	CcSEcCtD
Clonidine—Hyperhidrosis—Etoposide—brain cancer	0.000414	0.00169	CcSEcCtD
Clonidine—ABCB1—telencephalon—brain cancer	0.00041	0.00546	CbGeAlD
Clonidine—ADRA2A—cerebellum—brain cancer	0.000409	0.00544	CbGeAlD
Clonidine—Anorexia—Etoposide—brain cancer	0.000409	0.00166	CcSEcCtD
Clonidine—Hypersensitivity—Carmustine—brain cancer	0.000408	0.00166	CcSEcCtD
Clonidine—Nausea—Hydroxyurea—brain cancer	0.000407	0.00166	CcSEcCtD
Clonidine—Hypotension—Etoposide—brain cancer	0.0004	0.00163	CcSEcCtD
Clonidine—SLC22A5—brain—brain cancer	0.000399	0.00531	CbGeAlD
Clonidine—Asthenia—Carmustine—brain cancer	0.000398	0.00162	CcSEcCtD
Clonidine—Hypersensitivity—Temozolomide—brain cancer	0.000395	0.00161	CcSEcCtD
Clonidine—Paraesthesia—Etoposide—brain cancer	0.000385	0.00157	CcSEcCtD
Clonidine—Asthenia—Temozolomide—brain cancer	0.000384	0.00157	CcSEcCtD
Clonidine—Dyspnoea—Etoposide—brain cancer	0.000382	0.00156	CcSEcCtD
Clonidine—Somnolence—Etoposide—brain cancer	0.000381	0.00155	CcSEcCtD
Clonidine—Diarrhoea—Carmustine—brain cancer	0.000379	0.00155	CcSEcCtD
Clonidine—Pruritus—Temozolomide—brain cancer	0.000379	0.00154	CcSEcCtD
Clonidine—Decreased appetite—Etoposide—brain cancer	0.000373	0.00152	CcSEcCtD
Clonidine—Gastrointestinal disorder—Etoposide—brain cancer	0.00037	0.00151	CcSEcCtD
Clonidine—Fatigue—Etoposide—brain cancer	0.000369	0.00151	CcSEcCtD
Clonidine—Dizziness—Carmustine—brain cancer	0.000366	0.00149	CcSEcCtD
Clonidine—Constipation—Etoposide—brain cancer	0.000366	0.00149	CcSEcCtD
Clonidine—Pain—Etoposide—brain cancer	0.000366	0.00149	CcSEcCtD
Clonidine—Diarrhoea—Temozolomide—brain cancer	0.000366	0.00149	CcSEcCtD
Clonidine—CYP3A4—endocrine gland—brain cancer	0.000366	0.00486	CbGeAlD
Clonidine—CYP2D6—endocrine gland—brain cancer	0.00036	0.00479	CbGeAlD
Clonidine—CYP1A1—brain—brain cancer	0.000357	0.00474	CbGeAlD
Clonidine—CYP2D6—head—brain cancer	0.000355	0.00472	CbGeAlD
Clonidine—Dizziness—Temozolomide—brain cancer	0.000354	0.00144	CcSEcCtD
Clonidine—Feeling abnormal—Etoposide—brain cancer	0.000353	0.00144	CcSEcCtD
Clonidine—Vomiting—Carmustine—brain cancer	0.000352	0.00144	CcSEcCtD
Clonidine—Gastrointestinal pain—Etoposide—brain cancer	0.00035	0.00143	CcSEcCtD
Clonidine—Rash—Carmustine—brain cancer	0.000349	0.00142	CcSEcCtD
Clonidine—Dermatitis—Carmustine—brain cancer	0.000349	0.00142	CcSEcCtD
Clonidine—Headache—Carmustine—brain cancer	0.000347	0.00141	CcSEcCtD
Clonidine—ABCB1—gonad—brain cancer	0.000343	0.00456	CbGeAlD
Clonidine—Vomiting—Temozolomide—brain cancer	0.000341	0.00139	CcSEcCtD
Clonidine—Urticaria—Etoposide—brain cancer	0.00034	0.00139	CcSEcCtD
Clonidine—Abdominal pain—Etoposide—brain cancer	0.000339	0.00138	CcSEcCtD
Clonidine—Body temperature increased—Etoposide—brain cancer	0.000339	0.00138	CcSEcCtD
Clonidine—Rash—Temozolomide—brain cancer	0.000338	0.00138	CcSEcCtD
Clonidine—Dermatitis—Temozolomide—brain cancer	0.000337	0.00137	CcSEcCtD
Clonidine—Headache—Temozolomide—brain cancer	0.000336	0.00137	CcSEcCtD
Clonidine—ABCB1—pituitary gland—brain cancer	0.000334	0.00444	CbGeAlD
Clonidine—ADRA2A—brain—brain cancer	0.000332	0.00442	CbGeAlD
Clonidine—CYP3A4—central nervous system—brain cancer	0.00033	0.00438	CbGeAlD
Clonidine—Nausea—Carmustine—brain cancer	0.000329	0.00134	CcSEcCtD
Clonidine—CYP2D6—central nervous system—brain cancer	0.000324	0.00431	CbGeAlD
Clonidine—ABCB1—medulla oblongata—brain cancer	0.000323	0.00429	CbGeAlD
Clonidine—Nausea—Temozolomide—brain cancer	0.000318	0.0013	CcSEcCtD
Clonidine—CYP2D6—cerebellum—brain cancer	0.000317	0.00422	CbGeAlD
Clonidine—Hypersensitivity—Etoposide—brain cancer	0.000316	0.00129	CcSEcCtD
Clonidine—Asthenia—Etoposide—brain cancer	0.000307	0.00125	CcSEcCtD
Clonidine—Pruritus—Etoposide—brain cancer	0.000303	0.00124	CcSEcCtD
Clonidine—ABCB1—midbrain—brain cancer	0.000295	0.00392	CbGeAlD
Clonidine—Diarrhoea—Etoposide—brain cancer	0.000293	0.00119	CcSEcCtD
Clonidine—ABCB1—spinal cord—brain cancer	0.000288	0.00382	CbGeAlD
Clonidine—Dizziness—Etoposide—brain cancer	0.000283	0.00115	CcSEcCtD
Clonidine—Vomiting—Etoposide—brain cancer	0.000272	0.00111	CcSEcCtD
Clonidine—Rash—Etoposide—brain cancer	0.00027	0.0011	CcSEcCtD
Clonidine—Dermatitis—Etoposide—brain cancer	0.00027	0.0011	CcSEcCtD
Clonidine—Headache—Etoposide—brain cancer	0.000268	0.00109	CcSEcCtD
Clonidine—ABCB1—endocrine gland—brain cancer	0.000259	0.00344	CbGeAlD
Clonidine—CYP2D6—brain—brain cancer	0.000258	0.00342	CbGeAlD
Clonidine—ABCB1—head—brain cancer	0.000256	0.0034	CbGeAlD
Clonidine—Nausea—Etoposide—brain cancer	0.000255	0.00104	CcSEcCtD
Clonidine—ABCB1—central nervous system—brain cancer	0.000233	0.0031	CbGeAlD
Clonidine—ABCB1—cerebellum—brain cancer	0.000228	0.00303	CbGeAlD
Clonidine—ABCB1—brain—brain cancer	0.000185	0.00246	CbGeAlD
Clonidine—CYP3A5—Metabolism—BSG—brain cancer	3.59e-05	0.000488	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—VAV1—brain cancer	3.59e-05	0.000488	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—SMO—brain cancer	3.57e-05	0.000486	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PTCH1—brain cancer	3.57e-05	0.000486	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SUFU—brain cancer	3.54e-05	0.000481	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.53e-05	0.00048	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GLI2—brain cancer	3.52e-05	0.00048	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HEY1—brain cancer	3.52e-05	0.000479	CbGpPWpGaD
Clonidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.49e-05	0.000475	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—GFAP—brain cancer	3.47e-05	0.000472	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.46e-05	0.000471	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—DLL1—brain cancer	3.45e-05	0.000469	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—GFAP—brain cancer	3.41e-05	0.000464	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ABR—brain cancer	3.39e-05	0.000461	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—BSG—brain cancer	3.39e-05	0.000461	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—IDH1—brain cancer	3.37e-05	0.000458	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—VAV1—brain cancer	3.35e-05	0.000456	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GLI1—brain cancer	3.31e-05	0.000451	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—VAV1—brain cancer	3.3e-05	0.000449	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HEY1—brain cancer	3.29e-05	0.000447	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—ENO2—brain cancer	3.28e-05	0.000446	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GLI2—brain cancer	3.27e-05	0.000446	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SHH—brain cancer	3.25e-05	0.000442	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HEY1—brain cancer	3.23e-05	0.00044	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	3.23e-05	0.000439	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—DLL1—brain cancer	3.22e-05	0.000439	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP2C9—brain cancer	3.19e-05	0.000433	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—DLL1—brain cancer	3.17e-05	0.000432	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SUFU—brain cancer	3.14e-05	0.000427	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—ENO2—brain cancer	3.14e-05	0.000427	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TRPC6—brain cancer	3.13e-05	0.000426	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.12e-05	0.000424	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—IDH1—brain cancer	3.09e-05	0.00042	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.08e-05	0.00042	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SMO—brain cancer	3.08e-05	0.000419	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PTCH1—brain cancer	3.08e-05	0.000419	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GLI1—brain cancer	3.08e-05	0.000419	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GFAP—brain cancer	3.03e-05	0.000412	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—PIK3CG—brain cancer	3.01e-05	0.00041	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP2C9—brain cancer	3e-05	0.000408	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	3e-05	0.000408	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SHH—brain cancer	2.93e-05	0.000399	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—VAV1—brain cancer	2.93e-05	0.000399	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SUFU—brain cancer	2.92e-05	0.000397	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—IDH1—brain cancer	2.92e-05	0.000397	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HEY1—brain cancer	2.87e-05	0.000391	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TRPC6—brain cancer	2.83e-05	0.000385	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—DLL1—brain cancer	2.82e-05	0.000383	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GFAP—brain cancer	2.82e-05	0.000383	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—IL2—brain cancer	2.79e-05	0.00038	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SMO—brain cancer	2.78e-05	0.000378	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTCH1—brain cancer	2.78e-05	0.000378	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—PIK3CG—brain cancer	2.78e-05	0.000378	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SHH—brain cancer	2.74e-05	0.000373	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—VAV1—brain cancer	2.72e-05	0.00037	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.72e-05	0.00037	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—BSG—brain cancer	2.71e-05	0.000368	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SHH—brain cancer	2.7e-05	0.000367	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HEY1—brain cancer	2.67e-05	0.000363	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ENO2—brain cancer	2.66e-05	0.000362	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TRPC6—brain cancer	2.64e-05	0.00036	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—DLL1—brain cancer	2.62e-05	0.000356	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—IL2—brain cancer	2.61e-05	0.000355	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TRPC6—brain cancer	2.6e-05	0.000354	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SMO—brain cancer	2.6e-05	0.000353	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTCH1—brain cancer	2.6e-05	0.000353	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTCH1—brain cancer	2.56e-05	0.000348	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SMO—brain cancer	2.56e-05	0.000348	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—BSG—brain cancer	2.55e-05	0.000347	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP2C9—brain cancer	2.54e-05	0.000346	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	2.52e-05	0.000343	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	2.51e-05	0.000341	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.5e-05	0.00034	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PIK3CG—brain cancer	2.46e-05	0.000335	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	2.46e-05	0.000335	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.44e-05	0.000333	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ENO2—brain cancer	2.44e-05	0.000332	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SHH—brain cancer	2.4e-05	0.000326	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—VEGFA—brain cancer	2.37e-05	0.000323	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.37e-05	0.000323	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VAV1—brain cancer	2.35e-05	0.000319	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—PIK3CG—brain cancer	2.34e-05	0.000319	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—IDH1—brain cancer	2.33e-05	0.000317	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TRPC6—brain cancer	2.31e-05	0.000314	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	2.31e-05	0.000314	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ENO2—brain cancer	2.3e-05	0.000314	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	2.28e-05	0.00031	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SMO—brain cancer	2.27e-05	0.000309	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTCH1—brain cancer	2.27e-05	0.000309	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SHH—brain cancer	2.23e-05	0.000303	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	2.22e-05	0.000303	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—VEGFA—brain cancer	2.22e-05	0.000302	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—IDH1—brain cancer	2.19e-05	0.000299	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—BSG—brain cancer	2.16e-05	0.000294	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TRPC6—brain cancer	2.15e-05	0.000292	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PIK3CG—brain cancer	2.13e-05	0.00029	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VAV1—brain cancer	2.12e-05	0.000288	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—IL2—brain cancer	2.12e-05	0.000288	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SMO—brain cancer	2.11e-05	0.000287	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTCH1—brain cancer	2.11e-05	0.000287	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	2.09e-05	0.000285	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NOTCH2—brain cancer	2.08e-05	0.000283	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.05e-05	0.000279	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	2.05e-05	0.000279	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	2.04e-05	0.000278	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HES1—brain cancer	2.02e-05	0.000275	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VAV1—brain cancer	1.98e-05	0.000269	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.96e-05	0.000267	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—IL2—brain cancer	1.96e-05	0.000266	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VAV1—brain cancer	1.95e-05	0.000265	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	1.92e-05	0.000262	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.9e-05	0.000259	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SPP1—brain cancer	1.87e-05	0.000254	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.86e-05	0.000253	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—IDH1—brain cancer	1.86e-05	0.000253	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ENO2—brain cancer	1.84e-05	0.00025	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HES1—brain cancer	1.82e-05	0.000248	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.82e-05	0.000247	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—VEGFA—brain cancer	1.8e-05	0.000245	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—brain cancer	1.79e-05	0.000244	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL2—brain cancer	1.78e-05	0.000242	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—IL2—brain cancer	1.77e-05	0.00024	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	1.74e-05	0.000236	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ENO2—brain cancer	1.73e-05	0.000236	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.73e-05	0.000236	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.73e-05	0.000235	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HES1—brain cancer	1.7e-05	0.000232	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IRS2—brain cancer	1.69e-05	0.00023	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.69e-05	0.00023	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SPP1—brain cancer	1.69e-05	0.000229	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HES1—brain cancer	1.68e-05	0.000228	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—brain cancer	1.68e-05	0.000228	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—BSG—brain cancer	1.67e-05	0.000227	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—IL2—brain cancer	1.65e-05	0.000224	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	1.62e-05	0.000221	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	1.62e-05	0.000221	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.61e-05	0.000219	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL2—brain cancer	1.6e-05	0.000218	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	1.6e-05	0.000217	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SPP1—brain cancer	1.57e-05	0.000214	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SPP1—brain cancer	1.55e-05	0.000211	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IRS2—brain cancer	1.52e-05	0.000207	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.51e-05	0.000206	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CG—brain cancer	1.5e-05	0.000205	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL2—brain cancer	1.5e-05	0.000204	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—APC—brain cancer	1.49e-05	0.000203	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	1.49e-05	0.000203	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HES1—brain cancer	1.49e-05	0.000203	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL2—brain cancer	1.47e-05	0.000201	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ENO2—brain cancer	1.47e-05	0.0002	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.44e-05	0.000196	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CG—brain cancer	1.44e-05	0.000196	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—IDH1—brain cancer	1.43e-05	0.000195	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IRS2—brain cancer	1.42e-05	0.000194	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.42e-05	0.000193	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IRS2—brain cancer	1.4e-05	0.000191	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HES1—brain cancer	1.38e-05	0.000188	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.38e-05	0.000187	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—brain cancer	1.36e-05	0.000185	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	1.36e-05	0.000185	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—APC—brain cancer	1.35e-05	0.000183	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.35e-05	0.000183	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.34e-05	0.000182	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.32e-05	0.000179	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.31e-05	0.000178	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.28e-05	0.000174	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	1.26e-05	0.000171	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—APC—brain cancer	1.26e-05	0.000171	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.24e-05	0.000169	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—APC—brain cancer	1.24e-05	0.000168	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.24e-05	0.000168	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—EGFR—brain cancer	1.23e-05	0.000167	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CG—brain cancer	1.22e-05	0.000166	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.22e-05	0.000166	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—RELA—brain cancer	1.16e-05	0.000158	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	1.16e-05	0.000157	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.16e-05	0.000157	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.15e-05	0.000156	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ENO2—brain cancer	1.13e-05	0.000154	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.13e-05	0.000153	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CG—brain cancer	1.12e-05	0.000152	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.1e-05	0.00015	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—APC—brain cancer	1.1e-05	0.00015	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CG—brain cancer	1.06e-05	0.000144	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—RELA—brain cancer	1.05e-05	0.000143	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL2—brain cancer	1.05e-05	0.000143	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.05e-05	0.000142	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCND1—brain cancer	1.02e-05	0.000139	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	0.000139	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APC—brain cancer	1.02e-05	0.000139	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	1.01e-05	0.000138	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1e-05	0.000136	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—RELA—brain cancer	9.82e-06	0.000134	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	9.76e-06	0.000133	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—RELA—brain cancer	9.67e-06	0.000132	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	9.61e-06	0.000131	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL2—brain cancer	9.47e-06	0.000129	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	9.3e-06	0.000127	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—brain cancer	9.23e-06	0.000126	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	9.14e-06	0.000124	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	8.92e-06	0.000121	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2—brain cancer	8.85e-06	0.00012	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—brain cancer	8.83e-06	0.00012	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2—brain cancer	8.71e-06	0.000118	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—brain cancer	8.62e-06	0.000117	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RELA—brain cancer	8.59e-06	0.000117	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	8.54e-06	0.000116	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	8.53e-06	0.000116	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—brain cancer	8.49e-06	0.000115	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—brain cancer	8.44e-06	0.000115	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	8.41e-06	0.000114	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—brain cancer	8.2e-06	0.000112	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	8.05e-06	0.00011	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—brain cancer	8.02e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RELA—brain cancer	7.98e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—brain cancer	7.97e-06	0.000108	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—brain cancer	7.96e-06	0.000108	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	7.93e-06	0.000108	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2—brain cancer	7.73e-06	0.000105	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—brain cancer	7.54e-06	0.000103	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	7.52e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	7.47e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—brain cancer	7.44e-06	0.000101	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—brain cancer	7.41e-06	0.000101	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	7.4e-06	0.000101	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—brain cancer	7.33e-06	9.97e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—brain cancer	7.24e-06	9.86e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2—brain cancer	7.19e-06	9.78e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—brain cancer	7.01e-06	9.53e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	6.94e-06	9.44e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—brain cancer	6.92e-06	9.41e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—brain cancer	6.81e-06	9.26e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—brain cancer	6.77e-06	9.21e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—brain cancer	6.74e-06	9.17e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—brain cancer	6.74e-06	9.17e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—brain cancer	6.66e-06	9.06e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	6.57e-06	8.94e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—brain cancer	6.51e-06	8.86e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	6.11e-06	8.31e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—brain cancer	6.08e-06	8.28e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—brain cancer	6.05e-06	8.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—brain cancer	6.05e-06	8.23e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.92e-06	8.05e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—brain cancer	5.68e-06	7.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—brain cancer	5.62e-06	7.65e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—brain cancer	5.59e-06	7.61e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—brain cancer	5.5e-06	7.48e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—brain cancer	5.2e-06	7.08e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—brain cancer	4.97e-06	6.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—brain cancer	4.61e-06	6.28e-05	CbGpPWpGaD
